BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morante V, Borghi M, Farina I, Michelini Z, Grasso F, Gallinaro A, Cecchetti S, Di Virgilio A, Canitano A, Pirillo MF, Bona R, Cara A, Negri D. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy. Viruses 2021;13:355. [PMID: 33672349 DOI: 10.3390/v13020355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 bin Umair M, Akusa FN, Kashif H, Seerat-e-fatima, Butt F, Azhar M, Munir I, Ahmed M, Khalil W, Sharyar H, Rafique S, Shahid M, Afzal S. Viruses as tools in gene therapy, vaccine development, and cancer treatment. Arch Virol. [DOI: 10.1007/s00705-022-05432-8] [Reference Citation Analysis]
2 Liu J, Fu M, Wang M, Wan D, Wei Y, Wei X. Cancer vaccines as promising immuno-therapeutics: platforms and current progress. J Hematol Oncol 2022;15:28. [PMID: 35303904 DOI: 10.1186/s13045-022-01247-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ku MW, Charneau P, Majlessi L. Use of lentiviral vectors in vaccination. Expert Rev Vaccines 2021;:1-16. [PMID: 34620025 DOI: 10.1080/14760584.2021.1988854] [Reference Citation Analysis]